SCHEMBL20230686

SCHEMBL20230686

CC1(C)c2ccccc2N(c2cccc(-c3ccc4c(c3)C(C)(C)c3cc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)ccc3N4c3ccccc3)c2)c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS5 Q9UNA0 1/20 0.36
MEN1 O00255 6/20 0.35
KMT2A Q03164 6/20 0.35
ALDH1A1 P00352 5/20 0.35
MAPT P10636 5/20 0.35
HPGD P15428 4/20 0.35
HSP90AA1 P07900 2/20 0.35
FAAH O00519 1/20 0.35
PKM P14618 1/20 0.35
HTT P42858 1/20 0.35
ATM Q13315 1/20 0.35
MGLL Q99685 1/20 0.35
LMNA P02545 4/20 0.35
KDM4E B2RXH2 3/20 0.35
GLA P06280 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.33
NTSR1 P30989 2/20 0.33
TSHR P16473 2/20 0.32
PGR P06401 2/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17206567 0.98 ALDH1A1 (0.38) ADAMTS5MEN1KMT2AALDH1A1MAPT
SCHEMBL13833106 0.96 MEN1 (0.36) ADAMTS5MEN1KMT2AALDH1A1MAPT
SCHEMBL13833099 0.96 MEN1 (0.36) ADAMTS5MEN1KMT2AALDH1A1MAPT
SCHEMBL20230674 0.96 MEN1 (0.38) ADAMTS5MEN1KMT2AALDH1A1MAPT
SCHEMBL17206574 0.95 MEN1 (0.35) ADAMTS5MEN1KMT2AALDH1A1MAPT
SCHEMBL20230688 0.94 MEN1 (0.36) ADAMTS5MEN1KMT2AALDH1A1MAPT
SCHEMBL20230673 0.94 MEN1 (0.36) ADAMTS5MEN1KMT2AALDH1A1MAPT
SCHEMBL13833109 0.94 MEN1 (0.38) ADAMTS5MEN1KMT2AALDH1A1MAPT
SCHEMBL17278581 0.94 MEN1 (0.38) ADAMTS5MEN1KMT2AALDH1A1MAPT
SCHEMBL20230680 0.93 MEN1 (0.35) ADAMTS5MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10892423-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-01-12 US disclosed
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-07 US disclosed
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180159050-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNE2, CCNT1 ADAMTS5 4720/4885MEN1 666/4885KMT2A 1608/4885
US-10892423-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNE2, CCNT1 ADAMTS5 4720/4885MEN1 666/4885KMT2A 1608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.